- Home
- DCI vs PCVX Comparison
DCI vs PCVX Comparison
Compare DCI & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DCI | PCVX |
|---|---|---|
| Founded | 1915 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Pollution Control Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.7B | 6.1B |
| IPO Year | 1987 | 2020 |
Fundamental Metrics
Financial Performance| Metric | DCI | PCVX |
|---|---|---|
| Price | $100.78 | $53.06 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 7 |
| Target Price | $98.00 | ★ $105.00 |
| AVG Volume (30 Days) | 553.7K | ★ 1.0M |
| Earning Date | 02-26-2026 | 02-24-2026 |
| Dividend Yield | ★ 1.17% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.21 | N/A |
| Revenue | ★ $3,726,200,000.00 | N/A |
| Revenue This Year | $4.69 | N/A |
| Revenue Next Year | $4.71 | N/A |
| P/E Ratio | $31.93 | ★ N/A |
| Revenue Growth | ★ 2.37 | N/A |
| 52 Week Low | $57.45 | $27.66 |
| 52 Week High | $103.78 | $93.77 |
Technical Indicators
Market Signals| Indicator | DCI | PCVX |
|---|---|---|
| Relative Strength Index (RSI) | 66.54 | 68.26 |
| Support Level | $99.29 | $44.85 |
| Resistance Level | $103.78 | $48.93 |
| Average True Range (ATR) | 1.83 | 2.67 |
| MACD | 0.66 | 0.75 |
| Stochastic Oscillator | 78.50 | 76.40 |
Price Performance
Historical ComparisonAbout DCI Donaldson Company Inc.
Donaldson is a leading manufacturer of filtration systems and replacement parts (including air filtration systems, liquid filtration systems, and dust, fume, and mist collectors). The company serves a diverse range of end markets, including construction, mining, agriculture, truck, and industrial. Its business is organized into three segments: mobile solutions, industrial solutions, and life sciences. Donaldson generated approximately $3.7 billion in revenue in its fiscal 2025.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.